Ledger.Open graph →
SEC Form D · filed March 22, 2012

BELLICUM PHARMACEUTICALS, INC

Offering
$25.0M
Sold
$19.9M
Exemption
—
Industry
Pharmaceuticals
Location
HOUSTON, TX
Type
—

People & firms on this filing (12)

Annemarie K. Moseley · Houston, TXExecKevin M. Slawin · Houston, TXExec · DirectorKen K. Moseley · Houston, TXExecJoseph K. Senesac · Houston, TXExecThomas J. Farrell · San Diego, CAExec · DirectorDavid M. Spencer · Houston, TXExecJames F. Brown · Walnut Creek, CADirectorMatthew Cowan · Menlo Park, CADirectorFrank M. Mcguyer · Houston, TXDirectorThomas J. Farrell · Houston, TXExec · DirectorDennis K. Stone · Dallas, TXDirectorWilliam J. Scott · St Peter Port, Y7Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗